CTAS posts Q1 earnings and revenue beat, with strong segment growth and a raised fiscal 2026 outlook.
Vous n'êtes pas connecté
GRMN's Q2 earnings and sales beat estimates, with strong growth across segments prompting a raised full-year revenue and EPS outlook.
CTAS posts Q1 earnings and revenue beat, with strong segment growth and a raised fiscal 2026 outlook.
CTAS posts Q1 earnings and revenue beat, with strong segment growth and a raised fiscal 2026 outlook.
ACN posts earnings beat for fourth-quarter fiscal 2025, with growth across segments and strong bookings, while issuing an upbeat fiscal 2026 guidance.
ACN posts earnings beat for fourth-quarter fiscal 2025, with growth across segments and strong bookings, while issuing an upbeat fiscal 2026 guidance.
DRI's first-quarter earnings miss expectations while revenues beat, sending the stock down 8% despite a raised sales outlook.
DRI's first-quarter earnings miss expectations while revenues beat, sending the stock down 8% despite a raised sales outlook.
ADBE tops fiscal Q3 estimates with 14% EPS growth, $5.99B revenue, and upbeat guidance as shares climb.
ADBE tops fiscal Q3 estimates with 14% EPS growth, $5.99B revenue, and upbeat guidance as shares climb.
Bath & Body Works lifts its full-year outlook after second-quarter strength, driven by sales growth, product launches and resilient profitability.
FDS's fourth-quarter fiscal 2025 earnings fall short of estimates, but revenues rise 6.2% year over year, with solid growth across regions.